PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 69 |
| PubMedID- 22022185 | It has been shown that atherosclerosis in patients with diabetes mellitus (dm) can lead to acute coronary artery disease, ischemic cerebral disease, and peripheral arterial disease (2). |
| PubMedID- 22576258 | The pathophysiology of atherosclerosis development in patients with diabetes mellitus (dm) is similar to that in nondiabetics. |
| PubMedID- 23904855 | In this study, the total number for atherosclerosis in patients with type 2 diabetes mellitus increased with the progression of renal dysfunction. |
| PubMedID- 21957962 | This may contribute to atherosclerosis in diabetes mellitus. |
| PubMedID- 25120969 | Effect of age and blood pressure on surrogate markers of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22421230 | Objectives: the goal of this study was to characterize the extent and composition of coronary atherosclerosis in patients with diabetes mellitus or the metabolic syndrome (met syn) presenting with acute coronary syndromes (acs). |
| PubMedID- 25253014 | Conclusion: the systolic longitudinal myocardial function of lv become compromised before reduced lv global systolic function in coronary atherosclerosis patients with type 2 diabetes mellitus. |
| PubMedID- 25875738 | However, little is known about the association between glycemic control and objective sleep architecture and its influence on arteriosclerosis in patients with type-2 diabetes mellitus (dm). |
| PubMedID- 19853860 | Objective: to compare aortic intima media thickness (aimt) to carotid intima media thickness (cimt) as a marker of early atherosclerosis in children with type 1 diabetes mellitus and to examine the associations of aimt to known cardiovascular risk factors. |
| PubMedID- 22394699 | Association between apolipoprotein e polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus. |
| PubMedID- 22368195 | Aims: several studies have demonstrated that type 2 diabetes mellitus (t2dm) is associated with accelerated atherosclerosis, which results in an increased risk of coronary vascular events. |
| PubMedID- 20593206 | The objective of this study is to investigate the correlation of urinary albumin excretion rate (uaer) with the incidence of coronary heart disease (chd), pathological characteristics and severity of coronary atherosclerosis in patients with type 2 diabetes mellitus (t2dm), and explore the efficacy of using the urinary albumin excretion rate (uaer) to predict the risk of chd in patients with t2dm. |
| PubMedID- 26198368 | Accelerated atherosclerosis in patients with diabetes mellitus contributes an increased risk of developing cardiovascular diseases including peripheral vascular disease (pvd). |
| PubMedID- 24988089 | This might be one of the causal pathogenic factors initiating accelerated atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 26345606 | Therefore, serms may also be effective in reducing the progression of arteriosclerosis in patients with diabetes mellitus. |
| PubMedID- 25975128 | [a relationship between cardiac structural and functional parameters, left ventricular contractility, and coronary atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 24593955 | Altered lipids and lipoprotein metabolism in chronic diabetes mellitus is associated with pathogenesis of atherosclerosis and other cardiovascular diseases. |
| PubMedID- 25456820 | High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 20194881 | Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. |
| PubMedID- 20516379 | The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (dapc) study: a randomized trial. |
| PubMedID- 22120969 | Glp-1 may prevent or delay the formation of atherosclerosis in diabetes mellitus by improving the function of enos. |
| PubMedID- 23574730 | Postprandial hyperglycemia and/or hyperlipidemia can contribute to development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24797048 | The present study was designed to investigate the association of polymorphisms xbai (rs693) and ecori (rs1042031) of the apob gene with plasma apob level, lipid levels and the different ultrasound phenotypes of carotid atherosclerosis in patients with diabetes mellitus type 2. |
| PubMedID- 24768387 | Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: prologue study. |
| PubMedID- 24423050 | The gstt1-null genotype and combined gstt1*0/gstm1*0 might be potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus [16]. |
| PubMedID- 25708055 | In conclusion, cumulative active and passive smoking exposures are significant risk factors for carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22330623 | The gstt1-0 genotype and gstt1-0/gstm1-0 haplotype might be a potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 24392103 | While pwv is affected by changes in instantaneous blood pressure, the cardio-ankle vascular index (cavi) is a blood pressure-independent index of systemic arterial stiffness, and is often used as a marker of early arteriosclerosis associated with hypertension, diabetes mellitus, dyslipidemia and smoking [5]. |
| PubMedID- 23230750 | According to the levels of cimt, 64 diabetic patients were classified into two groups: diabetes mellitus without atherosclerosis (a group, n = 37) and diabetes mellitus with atherosclerosis (b group, n = 27). |
| PubMedID- 20605247 | According to the levels of carotid intima-media thickness (cimt), 36 diabetic patients were classified into two groups, the diabetes mellitus without atherosclerosis (dm-as, n=20) and diabetes mellitus with atherosclerosis (dm+as, n=16). |
| PubMedID- 20004424 | We investigated the relationship between hemoglobin concentration and various factors as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus. |
| PubMedID- 20538123 | Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. |
| PubMedID- 25509887 | Aim: to study the prognostic value of multifocal atherosclerosis (mfa) in patients with diabetes mellitus (dm) at high risk for myocardial ischemia who need coronary angiography (cag). |
| PubMedID- 23678326 | Chronic subclinical inflammation is considered to be important for the initiation and / or progression of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 25851542 | [33] suggested that ga was a more valuable index than hba1c for predicting the progression of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 21996253 | Aims: to analyze the relationship between serum levels of osteocalcin and parameters of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24678948 | The aim of this study was to investigate the relationships of subcutaneous and visceral abdominal fat with carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22827403 | The aim of our study was to evaluate serum amyloid a (saa), an acute phase reactant, and carotid intima-media thickness (cimt) as a valid predictor of atherosclerosis in women with gestational diabetes mellitus (gdm). |
| PubMedID- 26069232 | Little data exist about the relationship of apoc-iii, triglycerides, and atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 20361178 | This pathogenic sequence establishes the molecular basis linking insulin resistance, inflammation and accelerated atherosclerosis in people with type 2 diabetes mellitus and may help account for the missing 30% cvd risk that cannot be explained by circulating cardiovascular risk factors [74, 76] (fig. |
| PubMedID- 26505665 | Method: this case-control study included 596 type 2 diabetes mellitus patients with carotid atherosclerosis and 379 patients without carotid atherosclerosis. |
| PubMedID- 24739810 | Increased levels of adma were found in the development of carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm) [22], in subjects with early asymptomatic carotid atherosclerosis [23], and especially in patients with chronic kidney disease (ckds) and rheumatoid arthritis [24]. |
| PubMedID- 26251624 | The development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm) may be due to hypercoagulability and platelet hyperaggregability,1,2 along with increased levels of platelet activation markers. |
| PubMedID- 23347332 | Conclusions: diabetes mellitus may be associated with subclinical atherosclerosis assessed by measurement of avp and cimt. |
| PubMedID- 25385870 | It is well known that hyperglycemia is a trigger of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 21483695 | Part of the increased susceptibility to atherosclerosis of patients with type 2 diabetes mellitus and the metabolic syndrome has been attributed to the decreased clearance of trps [5], [31], [32]. |
| PubMedID- 21747057 | Background: endothelial dysfunction contributes to the development of atherosclerosis in patients with diabetes mellitus, but the mechanisms of endothelial dysfunction in this setting are incompletely understood. |
| PubMedID- 25537059 | Background: we aimed to investigate the association of toenail onychomycosis with subclinical atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 20108050 | Since postprandial lipoproteins are atherogenic, the delay in clearance of these particles could play an important role in the development of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 21779189 | Leptin and adiponectin can be more relevant to atherosclerosis in subjects with obesity and diabetes mellitus than conventional atherosclerotic factors such as bp and lipid levels [7, 14, 15]. |
Page: 1 2